help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, B.
Right arrow Articles by Moller, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, B.
Right arrow Articles by Moller, D. E.

Molecular Endocrinology, Vol 10, 1457-1466, Copyright © 1996 by Endocrine Society

ARTICLES

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

B Zhang, J Berger, E Hu, D Szalkowski, S White-Carrington, BM Spiegelman and DE Moller
Department of Molecular Endocrinology, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

Recent studies indicate that a peroxisome proliferator-activated receptor, PPAR gamma, functions as an important adipocyte determination factor. In contrast, tumor necrosis factor-alpha (TNF alpha) inhibits adipogenesis, causes dedifferentiation of mature adipocytes, and reduces the expression of several adipocyte-specific genes. Here, we report that treatment of 3T3-L1 adipocytes with TNF alpha resulted in a time- and concentration-dependent decrease in PPAR gamma mRNA expression to the level detected in preadipocytes. PPAR gamma mRNA levels were reduced by 95% with 3 nM TNF alpha treatment for 24 h. Half- maximal effects were seen after 3 h treatment with 3 nM TNF alpha or with 50 pM TNF alpha (24-h exposure). Parallel reductions in PPAR gamma protein levels were also observed after treatment of 3T3-L1 adipocytes with TNF alpha. Using a ribonuclease protection assay, both alternatively spliced PPAR gamma isoforms (gamma 1 and gamma 2) were shown to be negatively regulated by TNF alpha. The down-regulation of PPAR gamma by TNF-alpha preceded the diminution in expression of other adipocyte-specific genes including CCAAT/enhancer binding protein and adipocyte fatty acid-binding protein (aP2). The effect of TNF alpha was specific for the gamma-isoform of PPARs, since the expression of PPAR delta mRNA was not affected by treatment with TNF alpha. Low level constitutive expression of PPAR gamma in 3T3-L1 adipocytes (at levels approximately 2- to 3-fold higher than in preadipocytes) partially blocked the inhibitory effect of TNF alpha on aP2 and adipsin expression. These findings support the following conclusions: 1) PPAR gamma expression is necessary for the maintenance of the adipocyte phenotype. 2) PPAR gamma, but not PPAR delta, expression is sufficient to attenuate TNF alpha-mediated effects on adipocyte phenotype. 3) Reduced PPAR gamma gene expression is likely to represent an important component of the mechanism by which TNF alpha exerts its antiadipogenic effects.


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
R. Zechner, P. C. Kienesberger, G. Haemmerle, R. Zimmermann, and A. Lass
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores
J. Lipid Res., January 1, 2009; 50(1): 3 - 21.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. Uto-Kondo, R. Ohmori, C. Kiyose, Y. Kishimoto, H. Saito, O. Igarashi, and K. Kondo
Tocotrienol Suppresses Adipocyte Differentiation and Akt Phosphorylation in 3T3-L1 Preadipocytes
J. Nutr., January 1, 2009; 139(1): 51 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. S. Lee, A Y. Kim, J. W. Choi, M. Kim, S. Yasue, H. J. Son, H. Masuzaki, K. S. Park, and J. B. Kim
Dysregulation of Adipose Glutathione Peroxidase 3 in Obesity Contributes to Local and Systemic Oxidative Stress
Mol. Endocrinol., September 1, 2008; 22(9): 2176 - 2189.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
E. S. Muise, B. Azzolina, D. W. Kuo, M. El-Sherbeini, Y. Tan, X. Yuan, J. Mu, J. R. Thompson, J. P. Berger, and K. K. Wong
Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor {gamma} and Altered Metabolic States
Mol. Pharmacol., August 1, 2008; 74(2): 403 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Cardiovascular DiseaseHome page
M. Collino, N. S.A. Patel, and C. Thiemermann
Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 179 - 197.
[Abstract] [PDF]

Home page
 J EndocrinolHome page
A I Martin, E Castillero, M Granado, M Lopez-Menduina, M A Villanua, and A Lopez-Calderon
Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis
J. Endocrinol., April 1, 2008; 197(1): 111 - 119.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Emanuelli, D. Eberle, R. Suzuki, and C. R. Kahn
Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance
PNAS, March 4, 2008; 105(9): 3545 - 3550.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
J. Wray and D. Bishop-Bailey
Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology
Exp Physiol, January 1, 2008; 93(1): 148 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. H. Remels, P. Schrauwen, R. Broekhuizen, J. Willems, S. Kersten, H. R. Gosker, and A. M. Schols
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
Eur. Respir. J., August 1, 2007; 30(2): 245 - 252.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. A. Barbour, C. E. McCurdy, T. L. Hernandez, J. P. Kirwan, P. M. Catalano, and J. E. Friedman
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Diabetes Care, July 1, 2007; 30(Supplement_2): S112 - S119.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Popa, M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef
The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
J. Lipid Res., April 1, 2007; 48(4): 751 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
X. Li, H. Kimura, K. Hirota, H. Sugimoto, N. Kimura, N. Takahashi, H. Fujii, and H. Yoshida
Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-{gamma} in human proximal renal tubular cells
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1041 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. L.G. Correia and W. G. Haynes
A Role for Plasminogen Activator Inhibitor-1 in Obesity: From Pie to PAI?
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2183 - 2185.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Y. Kim, K. Tillison, J.-H. Lee, D. A. Rearick, and C. M. Smas
The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-{alpha} in 3T3-L1 adipocytes and is a target for transactivation by PPAR{gamma}
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E115 - E127.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Hummasti and P. Tontonoz
The Peroxisome Proliferator-Activated Receptor N-Terminal Domain Controls Isotype-Selective Gene Expression and Adipogenesis
Mol. Endocrinol., June 1, 2006; 20(6): 1261 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Gao, Q. He, B. Peng, P. J. Chiao, and J. Ye
Regulation of Nuclear Translocation of HDAC3 by I{kappa}B{alpha} Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor {gamma} Function
J. Biol. Chem., February 17, 2006; 281(7): 4540 - 4547.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Tang, A. Guilherme, A. Chakladar, A. M. Powelka, S. Konda, J. V. Virbasius, S. M. C. Nicoloro, J. Straubhaar, and M. P. Czech
An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPAR{gamma}, adipogenesis, and insulin-responsive hexose transport
PNAS, February 14, 2006; 103(7): 2087 - 2092.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
X. Liang, T. Kanjanabuch, S.-L. Mao, C.-M. Hao, Y.-W. Tang, P. J. Declerck, A. H. Hasty, D. H. Wasserman, A. B. Fogo, and L.-J. Ma
Plasminogen activator inhibitor-1 modulates adipocyte differentiation
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E103 - E113.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S Soumian, R Gibbs, A Davies, and C Albrecht
mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease
J. Clin. Pathol., December 1, 2005; 58(12): 1255 - 1260.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Granneman, P. Li, Z. Zhu, and Y. Lu
Metabolic and cellular plasticity in white adipose tissue I: effects of {beta}3-adrenergic receptor activation
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E608 - E616.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A Schaffler and H Herfarth
Creeping fat in Crohn's disease: travelling in a creeper lane of research?
Gut, June 1, 2005; 54(6): 742 - 744.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. She, S. Xiong, S. Hazra, and H. Tsukamoto
Adipogenic Transcriptional Regulation of Hepatic Stellate Cells
J. Biol. Chem., February 11, 2005; 280(6): 4959 - 4967.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Kudo, A. Sugawara, A. Uruno, K. Takeuchi, and S. Ito
Transcription Suppression of Peroxisome Proliferator-Activated Receptor {gamma}2 Gene Expression by Tumor Necrosis Factor {alpha} via an Inhibition of CCAAT/ Enhancer-binding Protein {delta} during the Early Stage of Adipocyte Differentiation
Endocrinology, November 1, 2004; 145(11): 4948 - 4956.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Deb, S. Amin, A. G. Imir, M. B. Yilmaz, T. Suzuki, H. Sasano, and S. E. Bulun
Estrogen Regulates Expression of Tumor Necrosis Factor Receptors in Breast Adipose Fibroblasts
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4018 - 4024.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Ruan, H. J. Pownall, and H. F. Lodish
Troglitazone Antagonizes Tumor Necrosis Factor-{alpha}-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-{kappa}B
J. Biol. Chem., July 18, 2003; 278(30): 28181 - 28192.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. P. Berger, A. E. Petro, K. L. Macnaul, L. J. Kelly, B. B. Zhang, K. Richards, A. Elbrecht, B. A. Johnson, G. Zhou, T. W. Doebber, et al.
Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein {gamma} Selective Modulator
Mol. Endocrinol., April 1, 2003; 17(4): 662 - 676.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Charriere, B. Cousin, E. Arnaud, M. Andre, F. Bacou, L. Penicaud, and L. Casteilla
Preadipocyte Conversion to Macrophage. EVIDENCE OF PLASTICITY
J. Biol. Chem., March 7, 2003; 278(11): 9850 - 9855.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kajita, T. Ishizuka, T. Mune, A. Miura, M. Ishizawa, Y. Kanoh, Y. Kawai, Y. Natsume, and K. Yasuda
Dehydroepiandrosterone Down-Regulates the Expression of Peroxisome Proliferator-Activated Receptor {gamma} in Adipocytes
Endocrinology, January 1, 2003; 144(1): 253 - 259.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Ruan, P. D. G. Miles, C. M. Ladd, K. Ross, T. R. Golub, J. M. Olefsky, and H. F. Lodish
Profiling Gene Transcription In Vivo Reveals Adipose Tissue as an Immediate Target of Tumor Necrosis Factor-{alpha}: Implications for Insulin Resistance
Diabetes, November 1, 2002; 51(11): 3176 - 3188.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Jiang, Q. Dallas-Yang, Z. Li, D. Szalkowski, F. Liu, X. Shen, M. Wu, G. Zhou, T. Doebber, J. Berger, et al.
Potentiation of Insulin Signaling in Tissues of Zucker Obese Rats After Acute and Long-Term Treatment With PPAR{gamma} Agonists
Diabetes, August 1, 2002; 51(8): 2412 - 2419.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Tamori, J. Masugi, N. Nishino, and M. Kasuga
Role of Peroxisome Proliferator-Activated Receptor-{gamma} in Maintenance of the Characteristics of Mature 3T3-L1 Adipocytes
Diabetes, July 1, 2002; 51(7): 2045 - 2055.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. P. Sewter, F. Blows, A. Vidal-Puig, and S. O'Rahilly
Regional Differences in the Response of Human Pre-Adipocytes to PPAR{gamma} and RXR{alpha} Agonists
Diabetes, March 1, 2002; 51(3): 718 - 723.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. S. Camp, A. Chaudhry, and T. Leff
A Novel Potent Antagonist of Peroxisome Proliferator-Activated Receptor {{gamma}} Blocks Adipocyte Differentiation But Does Not Revert the Phenotype of Terminally Differentiated Adipocytes
Endocrinology, July 1, 2001; 142(7): 3207 - 3213.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Fruhbeck, J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E827 - E847.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Iwata, T. Haruta, I. Usui, Y. Takata, A. Takano, T. Uno, J. Kawahara, E. Ueno, T. Sasaoka, O. Ishibashi, et al.
Pioglitazone Ameliorates Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator-Activated Receptor-{gamma}
Diabetes, May 1, 2001; 50(5): 1083 - 1092.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
L. Meng, J. Zhou, H. Sasano, T. Suzuki, K. M. Zeitoun, and S. E. Bulun
Tumor Necrosis Factor {{alpha}} and Interleukin 11 Secreted by Malignant Breast Epithelial Cells Inhibit Adipocyte Differentiation by Selectively Down-Regulating CCAAT/Enhancer Binding Protein {{alpha}} and Peroxisome Proliferator-activated Receptor {{gamma}}: Mechanism of Desmoplastic Reaction
Cancer Res., March 1, 2001; 61(5): 2250 - 2255.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. Zhou, B. Gurates, S. Yang, S. Sebastian, and S. E. Bulun
Malignant Breast Epithelial Cells Stimulate Aromatase Expression via Promoter II in Human Adipose Fibroblasts: An Epithelial-Stromal Interaction in Breast Tumors Mediated by CCAAT/Enhancer Binding Protein {beta}
Cancer Res., March 1, 2001; 61(5): 2328 - 2334.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. W. Valyasevi, S. C. Jyonouchi, C. M. Dutton, N. Munsakul, and R. S. Bahn
Effect of Tumor Necrosis Factor-{{alpha}}, Interferon-{{gamma}}, and Transforming Growth Factor-{beta} on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 903 - 908.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
A. Valladares, A. M. Alvarez, J. J. Ventura, C. Roncero, M. Benito, and A. Porras
p38 Mitogen-Activated Protein Kinase Mediates Tumor Necrosis Factor-{{alpha}}-Induced Apoptosis in Rat Fetal Brown Adipocytes
Endocrinology, December 1, 2000; 141(12): 4383 - 4395.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. T. Nadler, J. P. Stoehr, K. L. Schueler, G. Tanimoto, B. S. Yandell, and A. D. Attie
The expression of adipogenic genes is decreased in obesity and diabetes mellitus
PNAS, October 10, 2000; 97(21): 11371 - 11376.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. L. Waite, E. C. Person, Y. Zhou, K.-H. Lim, T. S. Scanlan, and R. N. Taylor
Placental Peroxisome Proliferator-Activated Receptor-{gamma} Is Up-Regulated by Pregnancy Serum
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3808 - 3814.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Zeghari, H. Vidal, M. Younsi, O. Ziegler, P. Drouin, and M. Donner
Adipocyte membrane phospholipids and PPAR-gamma expression in obese women: relationship to hyperinsulinemia
Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E736 - E743.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Sartippour and G. Renier
Differential Regulation of Macrophage Peroxisome Proliferator-Activated Receptor Expression by Glucose : Role of Peroxisome Proliferator-Activated Receptors in Lipoprotein Lipase Gene Expression
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 104 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. Desvergne and W. Wahli
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Endocr. Rev., October 1, 1999; 20(5): 649 - 688.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. J. Moreno-Aliaga and F. Matsumura
Endrin Inhibits Adipocyte Differentiation by Selectively Altering Expression Pattern of CCAAT/Enhancer Binding Protein-alpha in 3T3-L1 Cells
Mol. Pharmacol., July 1, 1999; 56(1): 91 - 101.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
G. Kwon, G. Xu, C. A. Marshall, and M. L. McDaniel
Tumor Necrosis Factor alpha -induced Pancreatic beta -Cell Insulin Resistance Is Mediated by Nitric Oxide and Prevented by 15-Deoxy-Delta 12,14-prostaglandin J2 and Aminoguanidine. A ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma  ACTIVATION AND iNOS EXPRESSION
J. Biol. Chem., June 25, 1999; 274(26): 18702 - 18708.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Berger, M. D. Leibowitz, T. W. Doebber, A. Elbrecht, B. Zhang, G. Zhou, C. Biswas, C. A. Cullinan, N. S. Hayes, Y. Li, et al.
Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma  and PPARdelta Ligands Produce Distinct Biological Effects
J. Biol. Chem., March 5, 1999; 274(10): 6718 - 6725.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Chinetti, S. Griglio, M. Antonucci, I. P. Torra, P. Delerive, Z. Majd, J.-C. Fruchart, J. Chapman, J. Najib, and B. Staels
Activation of Proliferator-activated Receptors alpha  and gamma  Induces Apoptosis of Human Monocyte-derived Macrophages
J. Biol. Chem., October 2, 1998; 273(40): 25573 - 25580.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
F. M. GREGOIRE, C. M. SMAS, and H. S. SUL
Understanding Adipocyte Differentiation
Physiol Rev, July 1, 1998; 78(3): 783 - 809.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. M. Valverde, T. Teruel, P. Navarro, M. Benito, and M. Lorenzo
Tumor Necrosis Factor-{alpha} Causes Insulin Receptor Substrate-2-Mediated Insulin Resistance and Inhibits Insulin-Induced Adipogenesis in Fetal Brown Adipocytes
Endocrinology, March 1, 1998; 139(3): 1229 - 1238.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Rabelo, A. Camirand, and J. E. Silva
3',5'-Cyclic Adenosine Monophosphate-Response Sequences of the Uncoupling Protein Gene Are Sequentially Recruited During Darglitazone-Induced Brown Adipocyte Differentiation
Endocrinology, December 1, 1997; 138(12): 5325 - 5332.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Y. Guan, Y. Zhang, L. Davis, and M. D. Breyer
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
Am J Physiol Renal Physiol, December 1, 1997; 273(6): F1013 - F1022.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. E. Hadri, A. Courtalon, X. Gauthereau, A.-M. Chambaut-Guerin, J. Pairault, and B. Feve
Differential Regulation by Tumor Necrosis Factor-alpha of beta 1-, beta 2-, and beta 3-Adrenoreceptor Gene Expression in 3T3-F442A Adipocytes
J. Biol. Chem., September 26, 1997; 272(39): 24514 - 24521.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Berger, M. Tanen, A. Elbrecht, A. Hermanowski-Vosatka, D. E. Moller, S. D. Wright, and R. Thieringer
Peroxisome Proliferator-activated Receptor-gamma Ligands Inhibit Adipocyte 11beta -Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
J. Biol. Chem., April 13, 2001; 276(16): 12629 - 12635.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Miyahara, L. Schrum, R. Rippe, S. Xiong, H. F. Yee Jr., K. Motomura, F. A. Anania, T. M. Willson, and H. Tsukamoto
Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation
J. Biol. Chem., November 10, 2000; 275(46): 35715 - 35722.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Moldes, F. Lasnier, X. Gauthereau, C. Klein, J. Pairault, B. Feve, and A.-M. Chambaut-Guerin
Tumor Necrosis Factor-alpha -induced Adipose-related Protein (TIARP), a Cell-surface Protein That Is Highly Induced by Tumor Necrosis Factor-alpha and Adipose Conversion
J. Biol. Chem., August 31, 2001; 276(36): 33938 - 33946.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society